Lumiracoxib-induced cholestatic liver injury
Author:
Affiliation:
1. Department of Gastroenterology; Royal North Shore Hospital; Australia
2. Department of Gastroenterology; Hornsby Hospital; Sydney; New South Wales; Australia
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12158/fullpdf
Reference6 articles.
1. Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment - findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial;Hawkey;Aliment Pharmacol Ther,2008
2. Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee;Sheldon;Clin Exp Rheumatol,2008
3. Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis;Geusens;Ther Clin Risk Manag,2008
4. Lumiracoxib inhibits cyclo-oxygenase completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?;Hinz;Ann Rheum Dis,2009
5. Withdrawal of lumiracoxib in Australia;Adverse Drug Reactions Advisory Committee, Adverse Drug Reactions Unit;Australian Adverse Drug Reactions Bulletin,2008
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current insights in the complexities underlying drug-induced cholestasis;Critical Reviews in Toxicology;2019-07-03
2. Nonsteroidal Anti-Inflammatory Drugs;Critical Care Toxicology;2017
3. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain;Expert Opinion on Investigational Drugs;2016-11-20
4. New Approaches to Investigate Drug-Induced Hypersensitivity;Chemical Research in Toxicology;2016-11-15
5. Hepatotoxicity induced by coxibs: how concerned should we be?;Expert Opinion on Drug Safety;2016-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3